| VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effects CR Heier, JM Damsker, Q Yu, BC Dillingham, T Huynh, ... EMBO molecular medicine 5 (10), 1569-1585, 2013 | 195 | 2013 |
| Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy2J Mouse Model of Congenital Muscular Dystrophy Q Yu, A Sali, J Van der Meulen, BK Creeden, H Gordish-Dressman, ... PloS one 8 (6), e65468, 2013 | 45 | 2013 |
| Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy K Uaesoontrachoon, JL Quinn, KS Tatem, JH Van Der Meulen, Q Yu, ... Human molecular genetics 23 (12), 3239-3249, 2014 | 44 | 2014 |
| An orphaned Mce‐associated membrane protein of Mycobacterium tuberculosis is a virulence factor that stabilizes Mce transporters EF Perkowski, BK Miller, JR McCann, JT Sullivan, S Malik, IC Allen, ... Molecular microbiology 100 (1), 90-107, 2016 | 40 | 2016 |
| The Sec Pathways and Exportomes of Mycobacterium tuberculosis BK Miller, KE Zulauf, M Braunstein Tuberculosis and the Tubercle Bacillus, 607-625, 2017 | 29 | 2017 |
| The effects of MyD88 deficiency on disease phenotype in dysferlin‐deficient A/J mice: role of endogenous TLR ligands K Uaesoontrachoon, HJ Cha, B Ampong, A Sali, J Vandermeulen, B Wei, ... The Journal of pathology 231 (2), 199-209, 2013 | 24 | 2013 |
| Structural similarities and differences between two functionally distinct SecA proteins, Mycobacterium tuberculosis SecA1 and SecA2 S Swanson, TR Ioerger, NW Rigel, BK Miller, M Braunstein, ... Journal of Bacteriology 198 (4), 720-730, 2016 | 20 | 2016 |
| Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis SA Montgomery, EF Young, PG Durham, KE Zulauf, L Rank, BK Miller, ... PLoS One 13 (9), e0204495, 2018 | 13 | 2018 |
| Mycobacterium tuberculosis SatS is a chaperone for the SecA2 protein export pathway BK Miller, R Hughes, LS Ligon, NW Rigel, S Malik, BR Anjuwon-Foster, ... Elife 8, e40063, 2019 | 12 | 2019 |
| VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects. EMBO Mol Med 5: 1569–1585 CR Heier, JM Damsker, Q Yu, BC Dillingham, T Huynh, ... | 9 | 2013 |
| The Sec pathways and exportomes of Mycobacterium tuberculosis. Microbiol Spectr 5 (2): TBTB2-0013-2016 BK Miller, KE Zulauf, M Braunstein | 6 | 2017 |
| Allosteric regulation of exocyst: Discrete activation of tethering by two spatial signals BK Miller, G Rossi, S Hudson, D Cully, RW Baker, P Brennwald Journal of Cell Biology 222 (3), e202206108, 2023 | 3 | 2023 |
| Blocking Toll-Like Receptor Pathway Using an Antagonist of TLR7, 8 and 9 Reduces Inflammation in Dystrophin Deficient mdx Mice (PD3. 004) Q Yu, T Huynh, A Sali, B Creeden, J Quinn, J Vandermeulen, C Spurney, ... Neurology 80 (7 Supplement), PD3. 004-PD3. 004, 2013 | 2 | 2013 |
| Pharmacokinetic considerations for optimizing inhaled spray-dried pyrazinoic acid formulations SB Yeshwante, P Hanafin, BK Miller, L Rank, S Murcia, C Xander, A Annis, ... Molecular Pharmaceutics 20 (9), 4491-4504, 2023 | | 2023 |
| Identification of a Chaperone for the SecA2 Protein Export Pathway of Mycobacterium tuberculosis B Miller | | 2018 |
| VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without hormonal side effects CR Heier, JM Damsker, Q Yu, BC Dillingham, T Huynh, ... | | |
